Tech Center 3700 • Art Units: 3774
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18421461 | STENT WITH SELECTIVE MEMBRANE COATING | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18267810 | STENTS FOR USE IN THE INTERVENTIONAL TREATMENT OF VASCULAR DISORDERS AND VASCULAR SURGERY | Final Rejection | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. |
| 18626714 | Self-Closing Outer Cuff Using Valve Foreshortening | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18327469 | Balloon Expandable Valve Securement Aids | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18737756 | PROSTHETIC VALVE WITH DUAL FRAMES RETAINED BY FABRIC | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18731039 | MULTI-PORTION REPLACEMENT HEART VALVE PROSTHESIS | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18656238 | CONNECTING SKIRT FOR ATTACHING A LEAFLET TO A FRAME OF A PROSTHETIC HEART VALVE | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18596062 | MULTI-PORTION REPLACEMENT HEART VALVE PROSTHESIS | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 19320925 | SYSTEMS, DEVICES, AND METHODS RELATING TO THE MANUFACTURE OF INTRAVASCULARLY IMPLANTABLE PROSTHETIC VALVES | Final Rejection | California Institute of Technology |
| 18195535 | DISTAL LIMB PERFUSION CANNULA STENT & STENT CANNULA COVER | Final Rejection | ABIOMED, Inc. |
| 18656886 | HEART VALVE PROSTHESIS | Non-Final OA | Medtronic, Inc. |
| 18458120 | MULTILAYERED VASCULARIZED CONSTRUCT | Non-Final OA | University of Washington |
| 18421615 | BIOABSORBABLE MEDICAL DEVICES | Non-Final OA | W. L. Gore & Associates, Inc. |
| 17203982 | DEVICES AND METHODS FOR APPROXIMATING THE CROSS-SECTIONAL PROFILE OF VASCULATURE HAVING BRANCHES | Final Rejection | W. L. Gore & Associates, Inc. |
| 17973331 | ABSORBABLE INTRAVASCULAR DEVICES FOR THE TREATMENT OF VENOUS OCCLUSIVE DISEASE | Non-Final OA | EFEMORAL MEDICAL, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy